This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Daiichi Sankyo Company, Limited. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Hiroki Sakai: Innovator in Pharmaceutical Development
Introduction
Hiroki Sakai is a notable inventor based in Takatsuki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that can improve renal function. His work focuses on innovative solutions to enhance health outcomes.
Latest Patents
Hiroki Sakai holds a patent for an amide derivative. The objective of this invention is to discover a novel pharmaceutical that exhibits an excellent tryptophanase inhibitory effect. This compound aims to suppress the worsening of renal function by reducing the production of indoxyl sulfate in the blood. The pharmaceutical composition includes a compound represented by a specific formula, which outlines the structural components and variations of the active ingredient.
Career Highlights
Sakai is currently associated with Daiichi Sankyo Company, Limited, where he continues to advance his research and development efforts. His work has the potential to significantly impact the treatment of renal issues, showcasing his commitment to improving patient health.
Collaborations
Hiroki Sakai collaborates with esteemed colleagues, including Tsuyoshi Soneda and Koji Matsumoto. These partnerships enhance the research environment and foster innovation within the pharmaceutical industry.
Conclusion
Hiroki Sakai's contributions to pharmaceutical innovation, particularly through his patent on amide derivatives, highlight his role as a key inventor in the field. His ongoing work at Daiichi Sankyo Company, Limited, along with his collaborations, positions him as a significant figure in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
